Jon Marc Wigginton - 30 Jan 2022 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Kleem Chaudhary, attorney-in-fact
Issuer symbol
N/A
Transactions as of
30 Jan 2022
Net transactions value
$0
Form type
4
Filing time
01 Feb 2022, 15:25:41 UTC
Previous filing
07 Jun 2021
Next filing
31 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPI Stock Option (Right to Buy) Award $0 +20,061 $0.000000 20,061 30 Jan 2022 Common Stock 20,061 $2.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest 1/3 on the first anniversary of the grant date and monthly thereafter through the third anniversary of the grant date, subject to the Reporting Persons continued service through such date.